Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-006022
Filing Date
2025-09-23
Accepted
2025-09-23 06:09:06
Documents
2
Period of Report
2025-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_092325.htm 6-K 6571
2 PRESS RELEASE exh_991.htm EX-99.1 5606
  Complete submission text file 0001171843-25-006022.txt   13190
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39179 | Film No.: 251331662
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)